Collagen production by macrophages in tumour encapsulation and dormancy. by Vaage, J. & Harlos, J. P.
Br. J. Cancer (1991), 63, 758 762 © Macmillan Press Ltd., 1991
Collagen production by macrophages in tumour encapsulation and
dormancy
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Summary Dormant and regressing implants of C3H mammary carcinoma MC2 were always found to be
surrounded by a cellular fibrous capsule where macrophages and T cells predominated as the cellular elements.
Macrophages were always closely associated with the collagen deposition, and stained with anti-collagen type I
immuno-peroxidase in tissue sections. The capacities of macrophages and T-lymphocytes to function in
collagen formation was investigated with the use of Nuclepore chambers implanted i.p. in normal mice. The
procollagen that entered the chambers via the pores, was assumed to have been produced by the packed layer
of peritoneal macrophages that adhered firmly to the outside of washed chambers. The adherent cells all
stained with Mac-I immuno-peroxidase, and phagocytosed yeast in short-term culture. The formation of
collagen fibres in the chambers was enhanced if the chambers contained T lymphocytes. It appears that
macrophages have the capacity to function as collagen producing cells in tumour encapsulation.
In the dormant state, tumour cells persist under growth
restraint for long periods. Tumour dormancy has been
explained as the prolonged arrest of cells in the G. phase of
the mitotic cycle (Gelfant, 1977). However, observations in
animal models have shown that the cells of dormant tumours
continue to divide with reduced frequency (Vaage & Pepin,
1985). The dormant state is inherently unstable and the
mechanisms involved are complex. Hormonal (Noble &
Hoover, 1975), nutritional (vascular) (Brem et al., 1976;
Weinhold et al., 1979), and host resistance factors (Eccles &
Alexander, 1975), are known to be involved in the restraint
of tumour growth. Tumour factors such as phenotypic diver-
sity (Weinhold et al., 1979), tumour invasive factors (e.g.
collagenase) (Woolley, 1982; Pauli et al., 1983), antigen shed-
ding (Davey et al., 1976), and immunosuppressive factors
(Eccles & Alexander, 1975), may be involved when growth
resumes.
The mammary carcinoma MC2, which with predictable
frequencies becomes dormant and/or regresses in normal
mice and in suboptimally immunised mice, is a suitable
model to study host reactions that restrain tumour growth. It
seems likely that tumour encapsulation may be at least par-
tially responsible for tumour dormancy and slow regression,
because every dormant and regressing MC2 implant examin-
ed histologically was enclosed in a cellular-fibrous capsule. A
connection between tumour fibrosis and tumour regression
has also been noted by Benjamin et al. (1977) and by Key
and Haskill (1981).
Because collagen deposition may be an important inhibitor
of tumour expansion, and because of the significance of
growth restraint (dormancy) in the natural control of cancer,
it is important to clarify the cellular aspects of tumour
encapsulation. Large numbers of T lymphocytes and macro-
phages were always seen to be closely associated with all
stages of the process of MC2 encapsulation (Vaage & Pepin,
1985), inviting speculation that the macrophages might be
involved in the collagen formation. Because of the long-
standing uncertainly about the origin and identity of the
productive cells in fibrotic conditions (Dumont, 1974; Boros,
1978; Rennard et al., 1984), and because mouse peritoneal
macrophages have recently been shown to produce as much
type I collagen as mouse tail fibroblasts in direct in vitro
comparisons (Vaage & Lindblad, 1990), the purpose of this
investigation was to study tumour encapsulation during the
primary immune response, and to determine whether the T
lymphocyte may influence the collagen forming capacity of
the macrophage. This would be a step toward understanding
some of the circumstances of pathologic fibrosis, as in, e.g.
tumour encapsulation.
Materials and methods
Mice
The mice used in these experiments were 8 to 10 week-old
female C3H/He mice, raised and kept in a filtered-air
environment.
Tumour
The mammary carcinoma MC2 developed spontaneously in a
multiparous C3H/He mouse and has been transplanted in
syngeneic female mice. The second transplant generation is
stored in liquid N2, and the tumour was used here in the
third to seventh transplant generations. This immunogenic
tumour has the characteristic of being rejected, after reaching
a size of as much as 10 mm (average 6.5 mm), by about 20%
of untreated, unimmunised, syngeneic female hosts. MC2
implants may also, after a period of growth, enter a dormant
period of 3 -8 weeks, which may end in rejection or in
renewed growth.
Tumours were removed from normal mice under the
inhalation anesthetic Penthrane (Abbott Laboratories, N.
Chicago, IL). Two 1 cu mm pieces of translucent, viable
tumour tissue were implanted s.c. by trocar in the right flank
to initiate new growth. The growth was measured with a
caliper twice weekly. Test implants for short-term histological
studies were single 4mm pieces of tumour placed s.c., with
forceps.
T-lymphocyte isolation
Inguinal, axillary, and brachial lymph nodes from 10-week-
old C3H/He mice or thymuses from 3-week-old C3H/He
mice, were teased apart in phosphate buffered saline (PBS)
with 10% foetal calf serum (FCS). The single cells in the
suspension were flushed through a 12 ml nylon wool column
using 25 ml PBS added 1 drop per s. The eluted cells were
spun down, resuspended in RPMI-1640 medium with 10%
FCS and incubated on plastic for 1 h to remove remaining
adherent cells. The proportion of T cells in the final suspen-
sion was determined by immunoperoxidase staining with
monoclonal antibody (MAb) against Thy 1.2, Lyt 1, with Lyt
2 markers.
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Immunoperoxidase staining
Tumours to be examined for macrophage and collagen type I
distribution were sectioned in a cryostat, at 7 rim, directly
after being excised. The sections were fixed in cold acetone
for 5 min and air dried. The staining followed the procedure
described by Taylor (1978). The following products were
used: Rat anti-mouse Lyt-1 Mab, and Lyt-2 Mab (products
1340 and 1350 from Becton-Dickinson, Mountainview, CA),
rat anti-mouse macrophage MAb (product Mac-i, No. 0282,
from Boehring-Mannheim, Indianapolis, IN), rabbit anti
mouse type I collagen antiserum (Dr Joseph Madri, Yale
University School of Medicine), goat anti-rat IgG-HPO
(horseradish peroxidase) (TAGO, Inc., Burlingame, CA), and
goat anti rabbit IgG (Cappel, Durham, NC). The Mac-I
marker is sensitive to the peroxidase neutralisation pretreat-
ment with 0.3% H202 in 100% methanol, and the neutralisa-
tion must therefore follow the incubation of cells with the
MAb. Slides were counterstained with Mayer's haematoxylin.
To enhance the colour of the diaminobenzidine oxide stain
for the photomicrographs in Figures 3 and 4, the pictures
were taken with dark blue (Kodak Wratten filter 47B) light.
Bloodflow test
The functional state of blood vessels in and around tumours
was compared in mice carrying growing tumours or carrying
dormant tumours. The mice received an injection of 0.1 ml of
0.02% resorcin-cystal violet in phosphate buffered saline via
the left ventricle. The tumours were removed for histologic
examination 5 min after the injection.
Nuclepore membrane chambers
The chambers implanted i.p. were made from a combination
of 0.4 tim and 0.051tm pore-size polycarbonate Nuclepore
membranes (Nuclepore, Pleasanton, CA) (Figure 1). After
24 h i.p., about 106 macrophages adhere, after gentle washing
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Figure 1 Nuclepore membrane chamber.
in PBS, to the outside of both sides of the chambers. The
0.4pm pores admit the collagen produced by the peritoneal
cells into the chamber, the 0.05jm pores do not. Thus, by
making the chambers from two different membranes, it could
be determined whether the collagen was produced by the
peritoneal cells outside the chambers, in which case the colla-
gen fibres would be seen on the inside of the 0.4ptm mem-
brane only, or produced by cells placed in the chambers, and
collagen seen on the inside of both membranes. The two
sides of the chambers were held together by a ring ofdouble-
sticky Scotch tape with a 5 mm hole. The chambers were
trimmed to an outside diameter of 9 mm with a 5 mm 'neck'
to provide a good seal for the channel through which the
chambers were filled with medium or with a cell suspension.
A 40 mm length of Intramedic tube PElO (Clay Adams,
Parsippany, NJ) was placed in the neck when the chambers
were made, and a 3 mm piece of the tubing was placed in the
chamber to keep the membranes separated. The chambers
were gas-sterilised with Anprolene (H.W. Anderson Prods.
Inc., Oyster Bay, NY). After a chamber was filled with
medium or cell suspension, the 40 mm tube was pulled out
and the chamber sealed. The chambers were implanted i.p.
through a mid-ventral incision with the mice under Pen-
thrane anaesthesia. The abdominal wall incisions were closed
with silk sutures, the skin incisions with wound clips.
Collagenase treatment ofNuclepore chambers
Freshly removed chambers were washed in PBS with magne-
tic stirring for 1 h. Chambers were then cut in half. One half
was placed in a 5 ml centrifuge tube with 1.5 ml PBS, the
second half in 1.5 ml PBS with 500 units of chromato-
graphically purified bacterial collagenase Type IV (Worthing-
ton, Freehold, NJ) and shaken for 2 h at 37°C. The chambers
were rinsed in PBS for 30 min and prepared for scanning
electron microscopy (SEM).
Electron microscopy
For SEM, Nuclepore chambers removed from the perito-
neum were placed directly in PBS with magnetic stirring for
1 h. The chambers were fixed in 3% gluteraldehyde for 24 h
and dehydrated in cold 50; 70; 80; 90; and 95% ethanol. The
capsules were opened and twice dehydrated in absolute etha-
nol for 15 min. The membranes were then treated with liquid
CO2 in a critical point drying chamber (Bomar SPC-50). The
membranes were mounted on sample stubs with conducting
graphite paint as adhesive and gold coated with a sputter
coater (Polaron SEM coating unit E5100). The specimens
were examined in an ETEC Autoscan at 20 kV.
For transmission electron microscopy (TEM), dehydrated
and critical-point-dried membranes were angle-shadowed
with platinum-carbon and vertically coated with carbon. The
specimen-replica were released from the specimen by 0.1 N
hydrochloric acid flotation, followed by 50% Chlorox flota-
tion to clean, and lastly, floated on distilled water to rinse.
The replica were mounted on colloidon-coated copper grids
and examined in a Siemens IOIA electron microscope.
Results
Capsuleformation
Every dormant or regressing MC2 implant removed for
histological examination was found to be surrounded by a
cellular-fibrous capsule. By the location of resorcin-crystal
violet, injected via the left ventricle, it was found that such
tumours were also invariably without active vascular supply,
even when the surrounding stroma was highly vascular. The
apparent effect of the encapsulation was to occlude the vas-
cular supply to the tumour, possibly by the suggested mech-
anism of collagen fibre shrinkage (Benjamin et al., 1977).
Progressively growing tumours, expanding into the surround-
ing stroma, were well vascularised. The fibrous encapsulation760 J. VAAGE & J.P. HARLOS
of non-expanding irradiated (3,000 r) control tumour im-
plants showed that the reaction was true encapsulation and
not compressed stromal tissue (pseudocapsule).
Figure 2 shows a detail of the capsule formation around a
6 mm tumour that had been dormant for 2 weeks after 3
weeks of growth. Figure 3 shows a detail from a cryostat
section from the same tumour stained with Mac-I immuno-
peroxidase for macrophage identification. It can be seen that
the more recently extravasated round mononuclear cells and
most of the spindle-shaped mononuclear cells closer to the
tumour were equally stained. Figure 4 shows a detail from
the same area of the tumour as shown in Figure 3, stained
with anti collagen type I immunoperoxidase. The staining of
cytoplasmic procollagen is dense in several of the cells. These
cells, by their similarity in number and peritumour location
compared to the stained cells in Figure 3, may be assumed to
also be macrophages.
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Figure 2 Detail from the tumour-stroma interface of a dormant
MC2 implant. The tumour is in the lower 1/4 of the picture.
Formalin fixed tissue. H&E stain. Bar = 50glm.
Figure 3 Cryostat section of the tumour shown in Figure 2. The
tumour is in the lower 1/4 of the picture. Mac-I immunoperoxi-
dase stain. Haematoxylin counterstain. Bar = 50 ttm.
Figure 4 Cryostat section close to the area shown in Figure 3.
The tumour is in the lower 1/4 of the picture. Collagen type I
immunoperoxidase stain. Haematoxylin counterstain. Bar=
50 lam.
Collagenformation into i.p. Nuclepore membrane chambers
Evidence of the ability of peritoneal macrophages to form
collagen in culture has been reported (Vaage & Lindbald,
1990). Because T cells and macrophages were always closely
associated at all stages of tumour encapsulation in this
investigation, the possible direct influence of nonadherent
lymphnode cells or thymocytes was studied with the use of
Nuclepore membrane chambers which were filled with a
suspension of lymphnode cells or thymus cells and implanted
i.p. Nuclepore chambers removed after 18 h, 48 h, and 72 h
i.p. were gently washed in PBS to remove the loosely adhe-
rent cells. By immunoperoxidase and giemsa staining, the
cells rinsed off were 75% macrophages, 20% polymorphs,
and 5% T lymphocytes. Unstained monoculear cells (pre-
sumably fibroblasts) were not found among the cells rinsed
off the chambers. The remaining adherent cells were, in a
4 mm2 area examined at 25 x, all mononuclear and stained
with Mac-1 immunoperoxidase. Washed chambers were also
placed in a 0.02% suspension of autoclaved yeast in culture
medium with 20% FCS. By 60 min, all of the cells had
ingested yeast. After 5 days in culture, all of the ingested
yeast had been digested. Controls ofcultured, freshly isolated
new-born mouse tail fibroblasts, did not stain with Mac-l,
and did not ingest yeast. Peritoneal fluid removed at the
same time as the chambers contained, on the average, 61%
macrophages, 33% neutrophils, 4% T lymphocytes, and 2%
eosinophils. Monocytes that did not stain with Mac-l, Lyt-1,
or Lyt-2, (fibroblasts) were not found in the peritoneal fluid.
The proportion of macrophages increased in the peritoneal
fluid during the 18 to 72 h sampling period.
SEM examination ofchambers containing 103 eluted nylon
wool adherent lymph node cells found that a thin, loose
mesh of fibres had formed on the inner surfaces of both the
0.05jtm and the 0.4gm pore-size membranes already 18 h
after i.p. implantation. This was a control that showed that a
mixed cell population that probably contained both macro-
phages and fibroblasts, produced collagen inside the cham-
bers. Chambers containing cultre medium or 103 P3 myeloma
cells, had a thin layer of fibres formed only on the inside of
the 0.4ym membrane after 72 h i.p. (Figure 5). Chambers
containing 103 lymph node T cells or thymocytes, had a
multi-layered net of fibres only on the inside of the 0.4 Am,
membrane after 48 h i.p. (Figure 6). TEM examination of the
fibres showed the 67 nm banding characteristic of collagen.
The fibres were dissolved after incubation in collagenase for
2 h. Table I summarises the results of this study.TUMOUR ENCAPSULATION 761
Figure 5 SEM of collagen fibres on the inside of the 0.4 iLm
membrane of a culture medium-containing chamber removed
after 72 h i.p. Scored (+) in Table I. Bar = 5 jim.
Figure 6 SEM of collagen fibres on the inside of the 0.4gm
membrane of a T lymphocyte-containing chamber removed after
48 h i.p. Scored (+ +) in Table 1. The perspective of the SEM
makes the T lymphocytes on the left appear larger than the true
scale. Bar = 1 jLm.
Table I Collagenformationinsidei.p. Nucleporechamberscontaining
different lymphoid cells
Length ofstay ip.
Cells in chambers 18 h 48 h 72 h
NWA-LNCa + + + + +
T-cellsb + + + + +
Thymocytesb + + + + +
P3 cells or CMb 0 + +
The sealed capsules contained approximately 103 cells of the listed
types. The amount ofcollagen fibres was estimated and scored at SEM
examination of code-numbered samples by two persons. + = < 10
fibres I10tlm '; + = 10-20 fibres 10 gAm-'; + + = >20 fibres 10
'm-; NWA-LNC, nylon wool adherent lymph nodecells; CM, culture
medium; aCollagen fibres on the inner surfaces of both membranes of
the Nuclepore chambers; bCollagen fibres on the inner surface of the
0.4pm membrane only.
Discussion
The origin and identity of the cells that produce collagen in
various circumstances ofpathologic fibrosis is a question that
has remained unresolved since Metchnikoff opened the
debate with lectures given at the Pasteur Institute in 1891. In
his lectures he proposed that blood monocytes could become
'fixed connective tissue cells' at sites of inflammation. The
lectures were published in English in 1893 (Metchnikoff,
1893). Metchnikoff's idea never gained acceptance however.
The fibre-producing cells in granuloma formation, in arthritic
and sclerotic conditions, and in wound healing, are generally
believed to be activated local fibroblasts. How non-circu-
lating, non-replicating fibroblasts could accumulate rapidly
during the productive phase of fibrosis has however, not been
explained. A recent report presented the first evidence, based
on western blot analysis, and on double immunofluorescence
with anti Mac-l and anti collagen type I antibodies, that
mouse peritoneal macrophages have the capacity to synthesise
collagen type I (Vaage & Lindblad, 1990). This introduces
the possibility that macrophages may also be productive cells
in certain types of pathologic fibrosis.
The present report presents evidence that macrophages
produced collagen in two experimental pathologic circum-
stances: in s.c. tumour encapsulation, and in the foreign body
reaction against i.p. Nuclepore chambers. It appears that
T-cells were involved when macrophages synthesised collagen
because collagen production into Nuclepore chambers was
enhanced when the capsules contained T-cells (Table I and
Figure 6). T-cells were also always seen in close association
with macrophages during the tumour encapsulation process.
The role of T-cells may be to direct and to enhance collagen
synthesis in certain pathologic conditions. It has already been
demonstrated that unspecified lymphocyte products (Johnson
& Ziff, 1976; Postlethwaite et al., 1984), unspecified T-cell
products (Wahl & Gately, 1983), interleukin-l, which is pro-
duced by many cells including T-cells (Goldring & Krane,
1987; Postlethwaite et al., 1988), and transforming growth
factor beta, produced by T-cells and macrophages (Roberts
et al., 1986; Raghow et al., 1987), influence collagen produc-
tion by cultured fibroblasts. The depletion ofT-cells inhibited
the formation of bacterial cell wall-induced hepatic granu-
lomas in vivo (Wahl et al., 1986), and reduced the ability of
immune spleen cells to form granulomas around Schistosoma
eggs in vitro (Bentley et al., 1982). The enhanced collagen
fibre formation seen in the Nuclepore chambers that con-
tained T-cells is therefore in agreement with observations in
other experimental systems.
Procollagen is secreted (exocytosed) as 325 nm-long units,
and collagen fibril formation follows spontaneously upon
enzymatic removal of the propeptide end pieces (Kivirikko &
Mylylla, 1984). It is likely therefore, that the 325 nm procol-
lagen units and the procollagen N-terminal and C-terminal
proteases pass through the 400 nm wide and 10,000 nm long
pores of the 0.4,im membrane before fibril formation inside
the chamber. The pores of the 0.05 jim membranes are 50 nm
wide and 6,000 nm long, which is apparently too narrow for
the passage of the procollagen molecules. The formation of
collagen fibres inside Nuclepore chambers via the pores is in
line with the observations of Pauli that the process of col-
lagen fibres formation does not require the close presence of
the collagen-producing cells, but with proceed spontaneously
in solutions of collagen monomers (Pauli et al., 1983).
When the present evidence, that collagen may be formed
by macrophages in experimental pathologic circumstances, is
confirmed by other investigators, this new information will
carry considerable theoretical and practical significance.
Long-standing questions about the formation of granulomas
(Narayanan et al., 1982), about fibrosis in certain forms of
cancer such as mammary carcinoma with productive fibrosis
(scirrhous) (Azzopardi, 1979), and about the pathology of
connective tissue diseases with suspected immunopathologic
etiology such as rheumatoid arthritis (Christian, 1971),
pulmonary fibrosis (Kravis et al., 1976), and progressive
systemic sclerosis (Rodman, 1971), could become better
understood.762 J. VAAGE & J.P. HARLOS
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